Abstracts

Previous | 1 | 2 | 3  Move down


  1. Höschl C.: Emotions from the psychiatric point of view. 3rd Interdisciplinary Medical Congress of the Czech Medical Academy "Emotions in medicine". Karlovy Vary (Carlsbad), 26-28 Nov 2010
  2. Horacek J, Flegr J, Tintera J, Novak T, Brunovsky M, Bubenikova-Valesova V, Palenicek T, Höschl C. Latent Toxoplasmosis Reduces Gray Matter Density in Schizophrenia but not in Controls. Voxel-Based-Morphometry (VBM) Study. 49th Annual Meeting of American College of Neuropsychopharmacology, Miami, FL, USA December 5-9, 2010
  3. Höschl C. Is the use of placebo necessary for objectivity of clinical trials? Psychiatrie 15, 2011; S1:19
  4. Hajek T, Cullis J, Blagdon R, Propper L, Duffy A, Kopecek M, Novak T, Höschl C, Alda M. Increased right inferior frontal gyrus gray matter in 2 cohorts of unaffected and affected offspring of bipolar parents – replication design, high-risk study. 9th international conference on bipolar disorder, Pittsburg, June 9-11, 2011
  5. Horacek J, Flegr J, Holub D, Tintera J, Novak T, Brunovsky M, Höschl C. Different impact of T.gondii seropositivity on the brain morphometry in schizophrenia and healthy control groups. Eur Psychiatry 26, 2011, S1 [epub]
  6. Höschl C, Fialová L. EPA Guidance on Conflicts of Interests. Eur Psychiatry 26, 2011, S1 [epub]
  7. Bares M, Novak T, Kopecek M, Stopkova P, Höschl C. Is serum folate level a predictor of response in depressive patients who failed to previous antidepressant treatments? A naturalistic study. Eur Psychiatry 26, 2011, S1 [epub]
  8. Höschl C, Bareš M, Novák T, Kopeček M, Stopková P: Efficacy of combinations of antidepressants in the treatment of resistant depression. Eur Psychiatry 26, 2011, S1 [epub]
  9. Höschl C. Is the use of placebo in clinical trials inevitable? Abstracts, XXVI. Czech and Slovak days of young neurologists, 12-13 May 2011, hotel Jana, Přerov. Neurologie pro praxi, 2011;12(Suppl.C):8
  10. Höschl C, Bareš M, Brunovský M, Kopeček M, Novák T, Kožený J. Prediction of a therapeutic response to antidepressants. Abstracts, 10th World Congress of Biological Psychiatry, 29 May- 2 June 2011, Prague
  11. Höschl C, Pálová E. Psychiatry and public health. In: "Strenghtening the system of public health". Abstract book of the 4th meeting of SAVEZ with international participation. 9-10 June 2011, Košice, Slovakia.
  12. Bares M, Novak T, Kopecek M, Stopkova P, Cermak J, Kozeny J, Höschl C. Antidepressant combinations and monotherapy in the treatment of resistant depression: a randomised, open-label study. Poster at 24th ECNP Congress in Paris, 5 September 2011.
  13. Horacek J, Flegr J, Tintera J, Verebova K, Spaniel F, Novak T, Brunovsky M, Bubenikova-Valesova V, Holub D, Palenicek T, Höschl C. Latent toxoplasmosis reduces gray matter density in schizophrenia but not in controls. Cutting Edge Psychiatry in Practice, 2011;1, S1:159. ISSN 2047-1882
  14. Höschl C. Placebo – deception or indispensable tool? Cutting Edge Psychiatry in Practice, 2011;1, S1:151. ISSN 2047-1882
  15. Höschl C. Basic concepts of schizophrenia: experimental approaches. Bull Clin Psychopharmacol 2011; 21 (Suppl. 2):548-549
  16. Horacek J, Bubenikova Valesova V, Palenicek T, Spaniel F, Höschl C. The ins and outs of the human model of schizophrenia. Bull Clin Psychopharmacol 2011; 21 (Suppl. 2):549
  17. Horáček J, Tintěra J, Ibrahim I, Holec M, Verébová K, Mikoláš P, Höschl C. Use of fMRI in assessment of emotional stimuli processing. In: 7th International workshop on functional magnetic resonance. Olomouc, Palacky University, 2011; p. 22 (abstract).
  18. Hajek T, Cullis J, Blagdon R, Duffy A, Propper L, Kopecek M, Novak T, Hoschl C, Alda M. Structural plasticity of the right inferior frontal gyrus in the course of bipolar disorders - interplay between compensatory changes, illness burden and lithium treatment. 50th Annual Meeting of American College of Neuropsychopharmacology, Dec 4-8, 2011. Waikoloa, Hawaii, USA
  19. Brunovský M, Horáček J, Tišlerová B, Novák T, Šóš P, Španiel F, Höschl C. Ketamine model of schizophrenia: QEEG and sLORETA study in healthy volunteers.In Neuroimaging through the lifespan: Brain development and brain diseases from adolescence to senescence. Joint meeting of ISNIP/ISBET/ECNP. Heidelberg: ISNIP, 2011; s. 15.
  20. Csémy L, Prajsová J, Mohr P, Höschl C. Epidemiology of generalized anxiety disorder (GAD) and other anxiety disorders in the Czech Republic.European Psychiatry, 2011; 26(Suppl. 1): 524.
  21. Brunovský M., Horáček J., Novák T., Šóš P., Kohútová B., Krajča V., Höschl C. QEEG measured changes of neuronal activity and brain connectivity induced by i.v. administration of ketamine in healthy volunteers and patients with depressive disorder. Psychiatrie, 16; 2012, S1:36.
  22. Höschl C, Fialová L. Conflict of interest in psychiatry. Eur. Psychiatry 2012; 27(1): CS05-02
  23. Bares M, Novak T, Höschl C.: Prediction of therapeutic outcome in treatment resistant depression. Eur. Psychiatry 2012; 27(1): CS02-02
  24. Kopecek M, Bares M, Novak T, Brunovsky M, Stopkova P, Krajca V, Höschl C.: Can we use changes in prefrontal function to predict antidepressant response in bipolar disorder? Eur. Psychiatry 2012; 27(1): AS 06-02
  25. Brunovsky M, Bares M, Kopecek M, Horacek J, Novak T, Sos P, Höschl C.: Reduction of prefrontal theta cordance in the prediction of response to antidepressants. Eur. Psychiatry 2012; 27(1): AS21-04
  26. Horacek J, Brunovsky M, Klirova M, Novak T, Tintera J, Höschl C.: Effect of low-frequency rTMS on electromagnetic tomography (LORETA) and regional brain metabolism (PET) in schizophrenia patients with auditory hallucinations. Eur. Psychiatry 2012; 27(1): AS21-03
  27. Höschl C. Bedřich Smetana - Art and Disease [in Czech] (2012). Lekársky obzor, LXI; S1:2-4. ISSN 0457-4214
  28. Höschl C. Sociobiology of depression [in Czech] (2012). Lekársky obzor, LXI; S1:14-15. ISSN 0457-4214
  29. Páleníček T, Horáček J, Brunovský M, Fujáková M, Tylš F, Höschl C. Neurobiology of effect of psychedelics and its' use in research and clinical practice [in Czech]. Lekársky obzor, LXI; S1:15. ISSN 0457-4214
  30. Brunovský M, Bareš M, Kopeček M, Novák T, Šóš P, Höschl C. Prediction of therapeutic response to antidepressants using QEEG cordance [in Slovak]. Lekársky obzor, LXI; S1:16. ISSN 0457-4214
  31. Šóš P, Klírová M, Horáček J, Novák T, Brunovský M, Höschl C. Quantitative EEG in prediction of antidepressive effect of ketamine [in Slovak]. Lekársky obzor, LXI; S1:16. ISSN 0457-4214
  32. Hajek T, Kopecek M, Hoschl C, Alda M. Reduced hippocampal volumes in bipolar disorders are masked by exposure to lithium - meta-analysis. P-16-008, 28th CINP World Congress of Neuropsychopharmacology. Stockholm, 3-7 June 2012
  33. Stein D, Márquez MS, Höschl C, Ahokas A, Oh KS, Jarema M, Avedisova A, Vavrusova L, Olivier V. Efficacy and tolerability of agomelatine in generalized anxiety disorder (GAD): A randomised double-blind, placebo-controlled trial with escitalopram as validator. P-04-019, 28th CINP World Congress of Neuropsychopharmacology. Stockholm, 3-7 June 2012
  34. Höschl C. How will we treat depression and anxiety in ten years? In: Raboch J. et al.(eds.), Sborník příspěvků (abstract book), IX. Congress of the Czech Psychiatric Society, pp. 18-20. Tribun EU 2012, ISBN 978-80-263-0243-8
  35. Bareš M, Novák T, Brunovský M, Stopková P, Höschl C. The prediction of response to antidepressive interventions in patients with bipolar depression - the change of QEEG cordance. In: Raboch J. et al.(eds.), Sborník příspěvků (abstract book), IX. Congress of the Czech Psychiatric Society, pp. 18-20. Tribun EU 2012, ISBN 978-80-263-0243-8
  36.  Höschl C.: Sigmund Freud and contemporary medicine. Psych. Danubina 2012; vol. 24, S1:204
  37.  Brunovsky M, Bares M, Novak T, Kopecek M, Sos P, Koprivova J, Krajca V & Höschl C.: The change of QEEG prefrontal theta cordance in the prediction of response to antidepressants. Psych. Danubina 2012; vol. 24, S1:205
  38. Höschl C. Integrating psychiatry within new medical curriculum. Čes. Slov. Psychiatrie, 108, 2012; S1:28
  39. Höschl C.: Placebo - deception or indispensable tool? Abstract book of the Student's scientific conference "Ageing 2012", Praha 26-27 Oct 2012 [in Czech], p. 17.
  40. Höschl C.: Principles of antidepressant pharmacotherapy in light of personalized medicine. Psychiatrie 17; 2013, S1:19. 55th Czech-Slovak psychopharmacological conference in Jeseník, 4.-8.1.2013.
  41. Bareš M., Novák T., Brunovský M., Kopeček M., Höschl C.: Prediction of treatment response to antidepressants in patients with treatment resistant depression- a combined model. Psychiatrie 17; 2013, S1:20-21. 55th Czech-Slovak psychopharmacological conference in Jeseník, 4.-8.1.2013.
  42. Horáček J., Brunovský M., Novák T., Šóš P., Páleníček T., Fujáková M., Höschl C.: Ketamine in models of psychoses. Psychiatrie 17; 2013, S1:29. 55th Czech-Slovak psychopharmacological conference in Jeseník, 4.-8.1.2013.
  43. Brunovský M., Horáček J., Šóš P., Novák T., Bareš M., Kohútová B., Höschl C.: Electrophysiological correlates of ketamine effect in depression and in healthy volunteers. Psychiatrie 17; 2013, S1:31. 55th Czech-Slovak psychopharmacological conference in Jeseník, 4.-8.1.2013.
  44. Höschl C, Fialová L. EPA Guidance Paper on Conflict of Interest. Abstract 2395, Eur Psychiatry, abstracts of 21st European Congress of Psychiatry, 6-9 April 2013, Nice, France.
  45. Höschl C. Why do some psychotropic drugs work and some others don´t? Abstract 2393, Eur Psychiatry, abstracts of 21st European Congress of Psychiatry, 6-9 April 2013, Nice, France.
  46. Höschl C. Burnout is a myth. Abstract 2394, Eur Psychiatry, abstracts of 21st European Congress of Psychiatry, 6-9 April 2013, Nice, France.

Previous | 1 | 2 | 3  Move up